Evolution of gag and gp41 in Patients Receiving Ritonavir-Boosted Protease Inhibitors

Manasa, J; Varghese, V; Pond, SLK; Rhee, SY; Tzou, PL; Fessel, WJ; Jang, KS; White, E; Rognvaldsson, T; Katzenstein, DA; Shafer, RW

Shafer, RW (reprint author), Stanford Univ, Dept Med, Div Infect Dis, Stanford, CA 94305 USA.

SCIENTIFIC REPORTS, 2017; 7 ( ):

Abstract

Several groups have proposed that genotypic determinants in gag and the gp41 cytoplasmic domain (gp41-CD) reduce protease inhibitor (PI) susceptibilit......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索